Okay, great.
We've done multiple reports, 14 or 15 of them over 10 years, with a lot of feedback from veterans over and over again on the same issues. I'm hoping that this study will do something a little different and hone in on the actual bureaucracy and the dynamics going on there.
Barry, I saw in your reports and heard a lot about the issues around data, that you cannot judge whether something is working effectively if you don't have data. It seems to me that if you don't have it, you don't have to deal with it. That is a bit of the perspective I have even with mefloquine and all the issues around that. Can you speak to that for me at all?